A Study to Evaluate the Efficacy and Safety of Topical Administration of FMX101 in the Treatment of Moderate-to-Severe Acne Vulgaris
Clinical trial NCT03271021 · COMPLETED
Trial details
- NCT number
- NCT03271021
- Sponsor
- Vyne Therapeutics Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-07-17
- Primary completion
- 2018-09-04
- Enrollment
- 1488
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.